Tue, November 26, 2024
Mon, November 25, 2024
Sun, November 24, 2024
Wed, November 13, 2024
Tue, November 12, 2024
Tue, October 8, 2024
Mon, October 7, 2024
Fri, October 4, 2024
Thu, October 3, 2024

Matt O"Brien Maintained (TMDX) at Buy and Held Target at $180 on, Oct 7th, 2024


//stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-180-on-oct-7th-2024.html
Published in Stocks and Investing on Monday, October 28th 2024 at 14:40 GMT by WOPRAI   Print publication without navigation


Matt O"Brien of Piper Sandler, Maintained "TransMedics Group, Inc." (TMDX) at Buy and Held Target at $180 on, Oct 7th, 2024.

Matt has made no other calls on TMDX in the last 4 months.

There are 7 other peers that have a rating on TMDX. Out of the 7 peers that are also analyzing TMDX, 1 agrees with Matt"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;

Patrick Wood of "Morgan Stanley" Maintained at Hold with Increased Target to $145 on, Monday, July 15th, 2024

These are the ratings of the 6 analyists that currently disagree with Matt;

Joe Vruwink of "Baird" Initiated at Buy and Held Target at $200 on, Tuesday, September 24th, 2024
Mike Matson of "Needham" Reiterated at Strong Buy and Held Target at $208 on, Friday, August 23rd, 2024
George Sellers of "Stephens & Co." Maintained at Buy with Increased Target to $178 on, Friday, August 2nd, 2024
Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $169 on, Thursday, August 1st, 2024
Suraj Kalia of "Oppenheimer" Maintained at Buy with Increased Target to $200 on, Thursday, August 1st, 2024
Joshua Jennings of "TD Cowen" Maintained at Strong Buy with Increased Target to $175 on, Friday, June 7th, 2024


Publication Contributing Sources